San Francisco · Hybrid · $95k–$120k/yr
Probably Genetic
About Probably Genetic
Probably Genetic focuses on helping patients living with severe, complex diseases. The company operates a data platform used by drug developers and patient advocacy groups to develop and launch treatments for these patients. Its technology discovers undiagnosed patients online, analyzes their disease state using machine learning and at-home testing, and enables compliant communication with patients, with the aim of helping people access diagnoses, clinical trials, and treatments as early as possible. The company reports annual recurring revenue growth of more than sixfold year over year and is profitable, having raised multiple rounds of funding from Silicon Valley investors including Threshold, Khosla, and Y Combinator. Its roadmap includes innovations in bioinformatics, machine learning, and drug development.
Open positions · 1
Company at a glance
Top Benefits
- Probably Genetic provides meaningful equity.
- Probably Genetic offers competitive salaries.
Location
Culture & values
We are a tight-knit group of hard-working, ambitious problem solvers united by a mission greater than ourselves.
We do well by doing right by patients.
We have built a lean, all-star team to help us bring our vision to life.
Frequently asked questions
Companies similar to Probably Genetic
Aira is an AI platform designed for procedural specialties that serves as the payer intelligence layer for medical device companies and surgical practices. The company automates critical back-office workflows while handling the full payer compliance lifecycle, including benefits verification, medical necessity determinations, prior authorization, and appeals management. By functioning as the intelligence layer powering market access teams, Aira helps healthcare providers and device manufacturers navigate the complexity of reimbursement processes to increase patient access to needed procedures. The platform addresses a key pain point in healthcare operations by streamlining the administrative burden that often delays care and complicates market entry for medical innovations.
Founded by Ayla, a former healthcare investor and EMT, and August, a founding engineer with deep expertise in voice and AI healthcare, this San Francisco-based company is transforming emergency medical services billing and claims. Backed by Eniac and Euclid Ventures at the pre-seed stage, the company is already live with customers and approaching $1M in annual recurring revenue. The lean, two-person founding team is deliberately building a small, elite organization focused on solving critical pain points in the EMS industry. With founders who combine both operational healthcare experience and technical sophistication, the company is positioned to bring much-needed innovation to a traditionally fragmented and inefficient market.
Aniva is a health optimization company. It positions itself as a preventive health operating system. It markets itself as Europe's most comprehensive blood check-up. Its mission is to simplify the journey to better health, making it accessible and effective for everyone.